Circulation Steg, P G, Szarek, M, Bhatt, D L, Bittner, V A, Bregeault, M-F, Dalby, A J, Diaz, R, Edelberg, J M, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Lecorps, G, Mahaffey, K W, Moryusef, A, Ostadal, P, Parkhomenko, A, Pordy, R, Roe, M T, Tricoci, P, Vogel, R, White, H D, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Clemmensen, P, Gislason, G, Davidsen, F & Videbaek, L 2019, ' Effect of Alirocumab on Mortality After Acute Coronary Syndromes : An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial ', Circulation, vol. 140, no. 2, pp. 103-112 . https://doi.org/10.1161/CIRCULATIONAHA.118.038840 CIRCULATION r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Circulation, 140(2), 103-112. LIPPINCOTT WILLIAMS & WILKINS Circulation : an official journal of the American Heart Association 140(2), 103-112 (2019). doi:10.1161/CIRCULATIONAHA.118.038840
Holman, R R, Bethel, M A, Mentz, R J, Thompson, V P, Lokhnygina, Y, Buse, J B, Chan, J C, Choi, J, Gustavson, S M, Iqbal, N, Maggioni, A P, Marso, S P, Öhman, P, Pagidipati, N J, Poulter, N, Ramachandran, A, Zinman, B, Hernandez, A F, EXSCEL Study Group & Serné, EH 2017, ' Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes ', New England Journal of Medicine, vol. 377, no. 13, pp. 1228-1239 . https://doi.org/10.1056/NEJMoa1612917 New England Journal of Medicine, 377(13), 1228-1239. Massachussetts Medical Society N Engl J Med